Liquidia Unable to Reverse Loss in United Therapeutics Patent Dispute

By Dean Seal A federal appeals court won't upend Liquidia's loss in a patent dispute with United Therapeutics that threatens to stall the U.S. launch of...

Related Keywords

Liquidia Yutrepia , ,United Therapeutics ,Federal Circuit ,Wall Street ,Patent Trial ,Appeal Board ,Dean Seal ,Article Normal ,Regulation Government Policy ,Patents ,Corporate Industrial News ,Intellectual Property Rights ,Industrial Property Rights ,Content Types ,Factiva Filters ,C Amp Ampe Industry News Filter ,Synd ,Regulation ,Government Policy ,Corporate ,Industrial News ,